Abstract:Cerebral ischemia (stroke) triggers a complex series of biochemical and molecular mechanisms that impairs the neurologic functions through breakdown of cellular integrity mediated by excitotoxic glutamatergic signalling, ionic imbalance, free-radical reactions, etc. These intricate processes lead to activation of signalling mechanisms involving calcium/calmodulin-dependent kinases (CaMKs) and mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK). The distribution of these transducers bring them in contact with appropriate molecular targets leading to altered gene expression, e.g. ERK and JNK mediated early gene induction, responsible for activation of cell survival/damaging mechanisms. Moreover, inflammatory reactions initiated at the neurovascular interface and alterations in the dynamic communication between the endothelial cells, astrocytes and neurons are thought to substantially contribute to the pathogenesis of the disease. The damaging mechanisms may proceed through rapid nonspecific cell lysis (necrosis) or by active form of cell demise (apoptosis or necroptosis), depending upon the severity and duration of the ischemic insult. A systematic understanding of these molecular mechanisms with prospect of modulating the chain of events leading to cellular survival/damage may help to generate the potential strategies for neuroprotection. This review briefly covers the current status on the molecular mechanisms of stroke pathophysiology with an endeavour to identify potential molecular targets such as targeting postsynaptic density-95 (PSD-95)/N-methyl-d-aspartate (NMDA) receptor interaction, certain key proteins involved in oxidative stress, CaMKs and MAPKs (ERK, p38 and JNK) signalling, inflammation (cytokines, adhesion molecules, etc.) and cell death pathways (caspases, Bcl-2 family proteins, poly (ADP-ribose) polymerase-1 (PARP-1), apoptosis-inducing factor (AIF), inhibitors of apoptosis proteins (IAPs), heat shock protein 70 (HSP70), receptor interacting protein (RIP), etc., besides targeting directly the genes itself. However, selecting promising targets from various signalling cascades, for drug discovery and development is very challenging, nevertheless such novel approaches may lead to the emergence of new avenues for therapeutic intervention in cerebral ischemia.

Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications

Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Network-Based Approach to Identify Potential Targets and Drugs That Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke

Cell Death Mechanisms in Cerebral Ischemia–Reperfusion Injury

Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy

Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural compounds

Regulated necrosis pathways: a potential target for ischemic stroke

Ischemic stroke: From pathological mechanisms to neuroprotective strategies

Necroptosis Signaling Pathways in Stroke: from Mechanisms to Therapies

Molecular Mechanisms of Cerebral Ischemia-Induced Neuronal Death.

The Role of Necroptosis in Cerebral Ischemic Stroke

Necroptosis Signaling Pathways in Stroke: from Mechanisms to Therapies.

Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation

Molecular targets in cerebral ischemia for developing novel therapeutics

Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis

Mechanisms of ischemic brain injury

Pathogenic mechanisms following ischemic stroke

Pathogenetic scenarios of the development of brain ischemia and the main elements of the ischemic cascade

Novel Therapeutic Strategies for Ischemic Stroke: Recent Insights into Autophagy